Frontiers Safety and therapeutic effects of personalized

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial - eBioMedicine

Extracellular vesicle-based biovectors in chronic wound healing: Biogenesis and delivery approaches: Molecular Therapy - Nucleic Acids

Integration of personalized drug delivery systems into digital health - ScienceDirect

Sustainability, Free Full-Text

JoX, Free Full-Text

What Are Precision Medicine and Personalized Medicine?

Cancer vaccines: the next immunotherapy frontier

First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial

Precision vs. Personalized Medicine

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders

Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study - eClinicalMedicine

Frontiers Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond

Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases - ScienceDirect

Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation

Personalized therapy: can it tame the COVID-19 monster?